Jan Kaiserle

Jan Kaiserle

Medical Systems Advisor
Jan Kaiserle specializes in medical research and evidence-based medicine. He explores the latest advancements in medical science, clinical trials, and healthcare technologies to improve diagnosis, treatment, and disease prevention. His content bridges the gap between clinical research and practice, providing meaningful insights for healthcare professionals.
Astellas: Innovating Healthcare with Robust R&D Investment
Clinical & Pharma Astellas: Innovating Healthcare with Robust R&D Investment

In a world where healthcare challenges continue to evolve with staggering complexity, Astellas emerges as a global pharmaceutical leader dedicated to transforming innovative science into tangible solutions for patients across the globe. With a market presence in over 70 countries and operating

Health DG Slams Insurers for Meddling in Clinical Decisions
Management & Administration Health DG Slams Insurers for Meddling in Clinical Decisions

In a striking development that has sent ripples through Malaysia's healthcare sector, Dr. Mahathar Abd Wahab, the Health Director-General, has issued a powerful reprimand to health insurers and third-party administrators for overstepping into the realm of clinical decision-making, highlighting a

NHS Shifts to Value-Based MedTech Procurement for Better Care
Management & Administration NHS Shifts to Value-Based MedTech Procurement for Better Care

In a groundbreaking move that could redefine healthcare delivery in the UK, the Department of Health and Social Care (DHSC) has unveiled a transformative strategy for medical technology procurement within the National Health Service (NHS). With an annual spend of roughly £10 billion on MedTech, the

GoodRx Stock Soars with TrumpRx and Kroger Partnerships
Tech & Innovation GoodRx Stock Soars with TrumpRx and Kroger Partnerships

What if millions of Americans could slash their prescription drug costs overnight with just a few clicks or a quick stop at their local pharmacy? This scenario is becoming a reality as GoodRx, a leading platform for medication savings, captures headlines with a staggering 14% stock surge in a

Why Is Home Health and Hospice Advocacy So Critical Now?
Tech & Innovation Why Is Home Health and Hospice Advocacy So Critical Now?

In the evolving landscape of U.S. healthcare, home health and hospice services have emerged as indispensable pillars, providing millions of Americans with the opportunity to receive compassionate, high-quality care in the familiarity of their own homes. As the population ages and chronic illnesses

How Did COVID-19 Impact Vitamin D Levels Worldwide?
Clinical & Pharma How Did COVID-19 Impact Vitamin D Levels Worldwide?

The COVID-19 pandemic, which swept across the globe with unprecedented speed, forced billions into isolation through lockdowns and social distancing measures, fundamentally altering daily life and exposing a quieter but equally concerning health issue: a significant decline in vitamin D levels

How Is Voice AI Transforming Healthcare Call Centers?
Tech & Innovation How Is Voice AI Transforming Healthcare Call Centers?

In a world where patients often spend frustrating minutes—or even hours—on hold, desperately seeking answers about appointments or medical concerns, a quiet revolution is underway. Picture a busy hospital call center overwhelmed by a flood of inquiries, with staff struggling to keep up as call

Government Shutdown Threatens Telehealth and HHS Operations
Tech & Innovation Government Shutdown Threatens Telehealth and HHS Operations

I'm thrilled to sit down with James Maitland, a renowned expert in healthcare policy and administration with a deep focus on Medicare, Medicaid, and telehealth regulations. With years of experience navigating the complexities of healthcare systems and a keen understanding of how policy shifts

Should You Opt for DNA Testing from Health Insurers?
Clinical & Pharma Should You Opt for DNA Testing from Health Insurers?

In an era where medical advancements are reshaping how treatments are approached, the concept of personalized medicine has emerged as a transformative force, offering the potential to customize healthcare based on individual genetic profiles. A striking development in this field comes from

Will Telehealth Flexibilities Survive Past September 30?
Tech & Innovation Will Telehealth Flexibilities Survive Past September 30?

As the calendar edges closer to September 30, a critical deadline looms over the landscape of American healthcare, threatening to upend the progress made in telehealth access through Medicare, which has been a lifeline for many. These flexibilities, expanded significantly during the COVID-19

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later